Brief: Cti Biopharma Reports Q4 & Full Year 2022 Financial Results

CTI Biopharma

06/03/2023 11:29

March 6 (Reuters) - Cti Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS
    * Q4 LOSS PER SHARE $0.14
    * QTRLY NET PRODUCT SALES OF $21.1 MILLION
    * AS OF DECEMBER 31, 2022, CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS TOTALED $79.9 MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.10, REVENUE VIEW $23.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPn5bQhLJa 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))